Every year on May 20, the global research community comes together to recognize International Clinical Trials Day (ICTD)—a moment to reflect on the importance of
Ontario has taken a pioneering step to accelerate the initiation of clinical trials with a new Universal Agreement for Clinical Trials (UACT) for Ontario. Developed
The Accelerating Clinical Trials (ACT) consortium, through an independent, international review panel, has selected CanReview to set up, initiate, and conduct a pan-Canadian single REB review
Ontario has long been an attractive jurisdiction for conducting high-quality clinical trials. However, we must do more to strengthen our status as a competitive jurisdiction
The Government of Ontario has announced new investments in the province’s thriving life sciences sector, including funding that will strengthen Ontario’s clinical trials environment. Unveiled
